Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Aigner

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2016
A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivoAlexander Ewe, Susanne Przybylski, Jana Burkhardt, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 19, 2024
Spray-drying of PEI-/PPI-based nanoparticles for DNA or siRNA deliverySandra Noske, Michael Karimov, Martin Krüger, et al.
Pharmaceutics|June 24, 2022
Characterization of Drug Release from Mesoporous SiO<sub>2</sub>-Based Membranes with Variable Pore Structure and GeometryFrank Baumann, Theresa Paul, Susan Wassersleben, et al.
Cellular and Molecular Life Sciences : CMLS|March 16, 2017
Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brainAnnette Burkhart, Thomas Lars Andresen, Achim Aigner, et al.
International Journal of Pharmaceutics|December 13, 2021
Non-viral siRNA transfection of primary mesenchymal stromal cells (MSCs): Assessment of tyrosine-modified PEI and PPI efficacy and biocompatibilitySandra Noske, Michael Karimov, Max Hansen, et al.
Analytical Chemistry|November 7, 2013
A novel method for the assessment of targeted PEI-based nanoparticle binding based on a static surface plasmon resonance systemSabrina Höbel, Doru Vornicescu, Marius Bauer, et al.
Toxicology and Applied Pharmacology|April 18, 2009
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexesAnastasia Malek, Olivia Merkel, Ludger Fink, et al.
Neoplasia (New York, N.Y.)|January 30, 2009
Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALKMarius Grzelinski, Florian Steinberg, Tobias Martens, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2014
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeuticsMatthaeus Stoehr, Christian Mozet, Andreas Boehm, et al.
Oncogene|August 13, 2002
Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivoAchim Aigner, Heiner Renneberg, Jörg Bojunga, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2016
A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivoAlexander Ewe, Susanne Przybylski, Jana Burkhardt, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 19, 2024
Spray-drying of PEI-/PPI-based nanoparticles for DNA or siRNA deliverySandra Noske, Michael Karimov, Martin Krüger, et al.
Pharmaceutics|June 24, 2022
Characterization of Drug Release from Mesoporous SiO<sub>2</sub>-Based Membranes with Variable Pore Structure and GeometryFrank Baumann, Theresa Paul, Susan Wassersleben, et al.
Cellular and Molecular Life Sciences : CMLS|March 16, 2017
Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brainAnnette Burkhart, Thomas Lars Andresen, Achim Aigner, et al.
International Journal of Pharmaceutics|December 13, 2021
Non-viral siRNA transfection of primary mesenchymal stromal cells (MSCs): Assessment of tyrosine-modified PEI and PPI efficacy and biocompatibilitySandra Noske, Michael Karimov, Max Hansen, et al.
Analytical Chemistry|November 7, 2013
A novel method for the assessment of targeted PEI-based nanoparticle binding based on a static surface plasmon resonance systemSabrina Höbel, Doru Vornicescu, Marius Bauer, et al.
Toxicology and Applied Pharmacology|April 18, 2009
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexesAnastasia Malek, Olivia Merkel, Ludger Fink, et al.
Neoplasia (New York, N.Y.)|January 30, 2009
Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALKMarius Grzelinski, Florian Steinberg, Tobias Martens, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2014
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeuticsMatthaeus Stoehr, Christian Mozet, Andreas Boehm, et al.
Oncogene|August 13, 2002
Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivoAchim Aigner, Heiner Renneberg, Jörg Bojunga, et al.
Pageof 18